Burstein HJ - Search Results

1

SABRE-B: an evaluation of paclitaxel and bevacizumab with or without sunitinib as first-line treatment of metastatic breast cancer.

Mayer EL, Dhakil S, Patel T, Sundaram S, Fabian C, Kozloff M, Qamar R, Volterra F, Parmar H, Samant M, Burstein HJ. Mayer EL, et al. Among authors: burstein hj. Ann Oncol. 2010 Dec;21(12):2370-2376. doi: 10.1093/annonc/mdq260. Epub 2010 May 23. Ann Oncol. 2010. PMID: 20497961 Free article. Clinical Trial.

2

A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinoma.

Mayer EL, DeMichele A, Rugo HS, Miller K, Waks AG, Come SE, Mulvey T, Jeselsohn R, Overmoyer B, Guo H, Barry WT, Huang Bartlett C, Koehler M, Winer EP, Burstein HJ. Mayer EL, et al. Among authors: burstein hj. Ann Oncol. 2019 Sep 1;30(9):1514-1520. doi: 10.1093/annonc/mdz198. Ann Oncol. 2019. PMID: 31250880 Free article. Clinical Trial.

3

Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer.

Mayer EL, Partridge AH, Harris LN, Gelman RS, Schumer ST, Burstein HJ, Winer EP. Mayer EL, et al. Among authors: burstein hj. Breast Cancer Res Treat. 2009 Oct;117(3):615-23. doi: 10.1007/s10549-009-0366-5. Epub 2009 Mar 18. Breast Cancer Res Treat. 2009. PMID: 19294501 Free PMC article. Clinical Trial.

4

A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancer.

Lin NU, Seah DS, Gelman R, Desantis S, Mayer EL, Isakoff S, Dipiro P, Krop IE, Come SE, Weckstein D, Winer EP, Burstein HJ. Lin NU, et al. Among authors: burstein hj. Breast Cancer Res Treat. 2013 Jun;139(2):403-10. doi: 10.1007/s10549-013-2551-9. Epub 2013 May 5. Breast Cancer Res Treat. 2013. PMID: 23645007 Clinical Trial.

5

Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy.

Burstein HJ, Lieberman G, Slamon DJ, Winer EP, Klein P. Burstein HJ, et al. Ann Oncol. 2005 Nov;16(11):1772-7. doi: 10.1093/annonc/mdi371. Epub 2005 Sep 8. Ann Oncol. 2005. PMID: 16150805 Free article. Clinical Trial.

6

Responses to subsequent anti-HER2 therapy after treatment with trastuzumab-DM1 in women with HER2-positive metastatic breast cancer.

Olson EM, Lin NU, DiPiro PJ, Najita JS, Krop IE, Winer EP, Burstein HJ. Olson EM, et al. Among authors: burstein hj. Ann Oncol. 2012 Jan;23(1):93-97. doi: 10.1093/annonc/mdr061. Epub 2011 Apr 29. Ann Oncol. 2012. PMID: 21531783 Free PMC article.

7

Phase I study of Doxil and vinorelbine in metastatic breast cancer.

Burstein HJ, Ramirez MJ, Petros WP, Clarke KD, Warmuth MA, Marcom PK, Matulonis UA, Parker LM, Harris LN, Winer EP. Burstein HJ, et al. Ann Oncol. 1999 Sep;10(9):1113-6. doi: 10.1023/a:1008323200102. Ann Oncol. 1999. PMID: 10572612 Free article. Clinical Trial.

8

A phase II study of lapatinib monotherapy in chemotherapy-refractory HER2-positive and HER2-negative advanced or metastatic breast cancer.

Burstein HJ, Storniolo AM, Franco S, Forster J, Stein S, Rubin S, Salazar VM, Blackwell KL. Burstein HJ, et al. Ann Oncol. 2008 Jun;19(6):1068-74. doi: 10.1093/annonc/mdm601. Epub 2008 Feb 17. Ann Oncol. 2008. PMID: 18283035 Free article. Clinical Trial.

9

Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer.

Burstein HJ, Kuter I, Campos SM, Gelman RS, Tribou L, Parker LM, Manola J, Younger J, Matulonis U, Bunnell CA, Partridge AH, Richardson PG, Clarke K, Shulman LN, Winer EP. Burstein HJ, et al. J Clin Oncol. 2001 May 15;19(10):2722-30. doi: 10.1200/JCO.2001.19.10.2722. J Clin Oncol. 2001. PMID: 11352965 Clinical Trial.

10

Impact of lapatinib plus trastuzumab versus single-agent lapatinib on quality of life of patients with trastuzumab-refractory HER2+ metastatic breast cancer.

Wu Y, Amonkar MM, Sherrill BH, O'Shaughnessy J, Ellis C, Baselga J, Blackwell KL, Burstein HJ. Wu Y, et al. Among authors: burstein hj. Ann Oncol. 2011 Dec;22(12):2582-2590. doi: 10.1093/annonc/mdr014. Epub 2011 Mar 15. Ann Oncol. 2011. PMID: 21406472 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

309 results

Search Page

Filters